Work

Abstract PS2-09-21: Real-world clinical outcomes and genomic insights for patients with PIK3CA-mutant metastatic breast cancer following progression on CDK4/6 inhibitor therapy

Year: 2026

Type: conference-abstract

Source: Clinical Cancer Research

DOI: 10.1158/1557-3265.sabcs25-ps2-09-21

Authors: M. R. Lloyd, L. Bucheit, D. Hintz, J. Liao, N. Vasan, K. Clifton, C. Ma, S. Wander

Institutions: Beth Israel Deaconess Medical Center, Guardant (United States), NYU Langone Health, NYU Langone’s Laura and Isaac Perlmutter Cancer Center, New York University, Washington University in St. Louis, Massachusetts General Hospital

Language: English

Topic: Advanced Breast Cancer Therapies

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W7130711829

Cites:

Cited by:

Related to: